NEW YORK (AP) — Several prospective jurors have been excused from the federal securities fraud trial of an ex-pharmaceutical company executive because they claimed they couldn't be impartial. Jury selection will continue Tuesday morning in Brooklyn. During jury questioning Monday, several potential jurors said they couldn't ignore Martin Shkreli's reputation for raising the price of a life-saving drug by 5,000 percent. One of them called him "the face of corporate greed.Read more on NewsOK.com